In a report released yesterday, Michael Carroll from RBC Capital maintained a Buy rating on CareTrust REIT (CTRE – Research Report), with a price target of $27.00. The company’s shares closed yesterday at $24.55.
According to TipRanks, Carroll is a 4-star analyst with an average return of 5.7% and a 60.73% success rate. Carroll covers the Real Estate sector, focusing on stocks such as Healthpeak Properties, Prologis, and Medical Properties.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for CareTrust REIT with a $25.75 average price target.
Based on CareTrust REIT’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $59.73 million and a net profit of $26.3 million. In comparison, last year the company earned a revenue of $51.81 million and had a net profit of $14.38 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CareTrust REIT (CTRE) Company Description:
CareTrust REIT, Inc. operates as real estate investment company, which engages in the ownership, acquisition, and leasing of healthcare-related properties. It offers independent living, memory care, and assisted, and skilled nursing facilities. The company was founded on October 29, 2013 and is headquartered in San Clemente, CA.
Read More on CTRE:
- CareTrust REIT Publishes Q1 2024 Supplemental Financials
- CareTrust REIT sees FY24 normalized FFO $1.42-$1.44, consensus $1.53
- CareTrust REIT reports Q1 normalized FFO 35c, consensus 37c
- CareTrust REIT acquires thre CCRCs in Southern California
- CareTrust REIT raises quarterly dividend to 29c from 28c per share
